Quibim

Quantitative Imaging Biomarkers in Medicine

QUIBIM applies advanced algorithms to medical images to objectively measure disease or treatment-derived alterations in organs and tissues, offering additional quantitative information to the naked eye of radiologists. Technology is available for hospitals and pharma companies through QUIBIM PRECISION platform.

Our company provides state of the art solutions for early diagnosis, lesion grading-phenotyping-staging, treatment selection/follow-up, in addition to the validation against clinical endpoints.

QUIBIM offers a head to toe imaging biomarkers solution. The development of each imaging biomarker involves a controlled step-by-step process, implemented by QUIBIM and adopted in 2013 by the European Society of Radiology (ESR) guidelines, to ensure accurate and consistent high quality measures.